a:head bio AG

a:head aims to develop new therapeutics for the treatment of brain disorders based on human cerebral organoids

[a:head bio AG @aheadbio]

We are proud to receive the 2021 @BoehringerIngelheim Grass Roots Innovation Prize #award #research #drugdiscovery #neurology
https://t.co/h8QfCl9ekV

[a:head bio AG @aheadbio]

With the start of our Series A roadshow we also launch our NEW WEBSITE at
https://t.co/7aJvfUGicm

Have a look! Hope you like it!

Thanks to the folks from https://t.co/y446I94Dfp for the professional collaboration!

[a:head bio AG @aheadbio]

@IMBA_Vienna @Knoblich_lab thank you for the shoutout, we are proud to be a member of the @viennabiocenter #startup #biotech #research #neurology
please follow us for news on our #drugdiscovery using cerebral #organoids

[a:head bio AG @aheadbio]

Guido Boehmelt @Boehringer: "Developing drugs to treat central nervous system disorders are an ongoing challenge for the pharmaceutical industry"

[a:head bio AG @aheadbio]

We are proud to receive the 2021 @BoehringerIngelheim Grass Roots Innovation Prize #award #research #drugdiscovery #neurology
https://t.co/h8QfCl9ekV

[a:head bio AG @aheadbio]

Oliver Szolar @aheadbio: "We are rethinking drug discovery by recreating human #brain #disease as faithfully as possible in the laboratory using cerebral #organoids."